Skip to main content
Caplight Logo









Belenos Biosciences Inc.

Belenos Biosciences Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://belenosbio.com/

Last Round

VC Round

Jul 17, 2024

Est. Valuation

$68.58M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Belenos Biosciences Inc. is a biotechnology company developing a pipeline of long-acting bispecific antibodies designed to transform the treatment of chronic inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

bispecific antibodychronic inflammatory diseaselong-acting therapeuticsdrug in-licensingclinical-stage biotechdual-target therapyantibody therapyasthma treatmentatopic dermatitis treatmentChina-out licensingbiologicsTSLP inhibitorIL-13 inhibitorCOPD treatmentchronic rhinosinusitis with nasal polypsCRSwNP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Belenos Biosciences Inc. Comparables

Compare Belenos Biosciences Inc. with similar companies based on industry and business-model similarity.

Belenos Biosciences Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Windward Bio
81%
Uniquity Bio
80%
Aclaris Therapeutics
78%

Belenos Biosciences Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 17, 2024

Key People

Founding team and executive leadership

Megan M. Dow

Chief Operating Officer, Co-Founder

Founding Team

Tania Dimitrova

Co-founder & Chief Financial Officer

Founding Team

Donnie McGrath

Chief Executive Officer

Executive Team

Belenos Biosciences Inc. Investors

Notable investors and investment history

Belenos Biosciences Inc. investors
InvestorRounds
OrbiMedVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 33% MoM.

  • Aug 20, 2026

    Grew 21% QoQ, from 14 to 17 employees.

Belenos Biosciences Inc. Filings

Explore SEC and related filing metadata, where available.

Belenos Biosciences Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Belenos Biosciences Inc.'s valuation, stock price, and market status.

Is Belenos Biosciences Inc. a public or private company?

Belenos Biosciences Inc. is a private company.

What is the current stock price of Belenos Biosciences Inc.?

Belenos Biosciences Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Belenos Biosciences Inc. worth (valuation)?

Belenos Biosciences Inc.'s valuation is estimated at $68.6M based on funding round data.

Can I buy Belenos Biosciences Inc. stock?

Belenos Biosciences Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Belenos Biosciences Inc.'s last funding round?

Belenos Biosciences Inc.'s most recent funding round was VC Round on July 17, 2024.

Who are the main investors in Belenos Biosciences Inc.?

Investor information for Belenos Biosciences Inc. is not publicly disclosed.

Will Belenos Biosciences Inc. IPO soon?

No public IPO plans have been announced for Belenos Biosciences Inc..

How can I track Belenos Biosciences Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Belenos Biosciences Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range12
Year Founded2024
Last FundingJul 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?